menu
    • menu

    Company profile for Hugel

    Suanfarma, at the Core of a Better Life.

    Virtual Booth

    Contact Supplier

    Jai Radhe Sales is your partner for all your sourcing needs.

    Virtual Booth

    Contact Supplier

    Centrient is a leading manufacturer of Beta-Lactam Antibiotics and a provider of next-generation Statins and Antifungals.

    Virtual Booth

    Contact Supplier

    Moehs Group, a reference company in the production of pharmaceutical active ingredients.

    Virtual Booth

    Contact Supplier

    Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Hugel will take a bold leap forward to become a global top-tier company that provides health and beauty to humanity and create value to realize a happy life. Hugel is in a leading position in the aesthetic and therapeutic market based on its excellent product strength and customer trust such as botulinum toxin formulation BOTULAX, HA filler 'THE CHAEUM' and bio cosmetic 'WELLAGE'. Hugel is undertaking a new leap forward as a ...
    Hugel will take a bold leap forward to become a global top-tier company that provides health and beauty to humanity and create value to realize a happy life. Hugel is in a leading position in the aesthetic and therapeutic market based on its excellent product strength and customer trust such as botulinum toxin formulation BOTULAX, HA filler 'THE CHAEUM' and bio cosmetic 'WELLAGE'. Hugel is undertaking a new leap forward as a global biopharmaceutical company, going beyond its domestic representative companies. In order to improve the quality of human life, we are creating new values for humanity.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Hugelkorearepublicofnew Flag
    Country
    Country
    South Korea
    Address
    Address
    61-20, Sinbuk-ro, Sinbuk-eup, Chuncheon-si, Gangwon-do 24206
    Telephone
    Telephone
    02-6966-1600 / 02-6966-1601
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    http://www.hugel.co.kr/en/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/hugel-inc
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Hugel Debuts Botulinum Toxin Letybo in Malaysia
    Hugel Debuts Botulinum Toxin Letybo in Malaysia

    10 Aug 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/hugel-launches-botulinum-toxin-letybo-in-malaysia-302525192.html

    PR NEWSWIRE
    10 Aug 2025
    Share Share
    BENEV Company and Hugel Inc. announce Letybo® commercialization
    BENEV Company and Hugel Inc. announce Letybo® commercialization

    25 Mar 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/benev-company-inc-and-hugel-inc-are-pleased-to-announce-that-letybo-letibotulinumtoxina-wlbg-is-now-fully-commercialized-in-the-us-marking-a-significant-milestone-in-the-neuromodulator-market-302409966.html

    PR NEWSWIRE
    25 Mar 2025
    Share Share
    FDA Issues Form 483 to Hugel, Inc.
    FDA Issues Form 483 to Hugel, Inc.

    23 Sep 2024

    // FDA

    https://www.fda.gov/media/182103/download

    FDA
    23 Sep 2024
    Share Share
    Hugel Receives FDA Approval in the United States of Letybo for Injection
    Hugel Receives FDA Approval in the United States of Letybo for Injection

    04 Mar 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/hugel-receives-fda-approval-in-the-united-states-of-letybo-letibotulinumtoxina-wlbg-for-injection-for-the-treatment-of-glabellar-lines-302078434.html

    PR NEWSWIRE
    04 Mar 2024
    Share Share
    Hugel Receives U.S. FDA Approval for Its Botulinum Toxin Letybo
    Hugel Receives U.S. FDA Approval for Its Botulinum Toxin Letybo

    03 Mar 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/hugel-receives-us-fda-approval-for-its-botulinum-toxin-letybo-302077919.html

    PR NEWSWIRE
    03 Mar 2024
    Share Share
    Hugel's 'Letybo' First in Korea to Obtain Marketing Approval from Australia
    Hugel's 'Letybo' First in Korea to Obtain Marketing Approval from Australia

    24 Nov 2022

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/hugels-letybo-first-in-korea-to-obtain-marketing-approval-from-australia-301686683.html

    PRNEWSWIRE
    24 Nov 2022
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search